You are here: Industry Insights > Market News

Market News

Alzheimer’s Disease: Charting the Course from Plaques to Promise Muhammad Farhan Khalid
May 28, 2025
New Tools，New Hope，New Frontier
Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines PR Newswire
July 31, 2025
Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH).
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company PR Newswire
July 31, 2025
Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment.
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan PR Newswire
July 30, 2025
Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition.
From the Alzheimer's Association International Conference 2025: SNAP Benefits Linked to Slower Cognitive Decline, 10-Year Study Finds. PR Newswire
July 30, 2025
Participating in the Supplemental Nutrition Assistance Program (SNAP) may help protect against age-related cognitive decline, suggests an analysis of a national study.
Touchlight Introduces mbDNA?: A “Best-In-Class" Circular Single Stranded DNA (ssDNA) Platform Enabling Superior Gene Editing Biotech Newswire
July 30, 2025
Touchlight, a pioneer in cell-free DNA innovation, is proud to announce the commercial launch of their new technology for non-viral gene editing, mbDNA?.
Telix H1 2025 Results: Investor Webcast Notification PR Newswire
July 30, 2025
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.
Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics PR Newswire
July 30, 2025
CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave? Ultrasound Imaging System
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) Partner for Landmark Proteomic Profiling Study in the Rhineland Study Cohort PR Newswire
July 29, 2025
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced a strategic collaboration with the German Center for Neurodegenerative Diseases.
Leo Cancer Care Receives FDA 510(k) Clearance for Marie? - A Revolutionary Upright Radiotherapy Platform PR Newswire
July 29, 2025
Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie?, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).